ALLERGAN PLC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-12-08: Reporting owner Meury William; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-08-05: Reporting owner Basgoz Nesli; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-06-08: Reporting owner SCHAISON PHILIPPE; Form 4; Security Stock Option (Right to Buy); Transaction Holding.
- 2016-06-08: Reporting owner SCHAISON PHILIPPE; Form 4; Security Stock Option (Right to buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-12-08 | Meury William Officer (Chief Commercial Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,807 0 owned after | $188.47 exercise price | 2017-02-14 | |
| 2016-08-05 | Basgoz Nesli Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +1,889 12,878 owned after | $97.62 exercise price | 2016-08-09 | |
| 2016-06-08 holding as of filing | SCHAISON PHILIPPE Officer (EVP, President Allergan Med) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 16,152 owned after | $112.20 exercise price | 2016-06-08 | |
| 2016-06-08 holding as of filing | SCHAISON PHILIPPE Officer (EVP, President Allergan Med) | 4 | Stock Option (Right to buy) Derivative · Direct | Holding | 16,387 owned after | $154.87 exercise price | 2016-06-08 | |
| 2016-06-08 holding as of filing | SCHAISON PHILIPPE Officer (EVP, President Allergan Med) | 4 | Stock Option (Right to buy) Derivative · Direct | Holding | 8,149 owned after | $289.75 exercise price | 2016-06-08 | |
| 2016-06-08 holding as of filing | SCHAISON PHILIPPE Officer (EVP, President Allergan Med) | 4 | Stock Option (Right to buy) Derivative · Direct | Holding | 8,676 owned after | $307.51 exercise price | 2016-06-08 | |
| 2016-06-08 holding as of filing | NAVARRE PAUL Officer (EVP, President Int'l Brands) | 4 | Stock Option (Right to buy) Derivative · Direct | Holding | 7,752 owned after | $108.86 exercise price | 2016-06-08 | |
| 2016-06-08 holding as of filing | NAVARRE PAUL Officer (EVP, President Int'l Brands) | 4 | Stock Option (Right to buy) Derivative · Direct | Holding | 8,156 owned after | $131.10 exercise price | 2016-06-08 | |
| 2016-06-08 holding as of filing | NAVARRE PAUL Officer (EVP, President Int'l Brands) | 4 | Stock Option (Right to buy) Derivative · Direct | Holding | 9,499 owned after | $154.87 exercise price | 2016-06-08 | |
| 2016-06-08 holding as of filing | NAVARRE PAUL Officer (EVP, President Int'l Brands) | 4 | Stock Option (Right to buy) Derivative · Direct | Holding | 7,726 owned after | $289.75 exercise price | 2016-06-08 | |
| 2016-06-08 holding as of filing | NAVARRE PAUL Officer (EVP, President Int'l Brands) | 4 | Stock Option (Right to buy) Derivative · Direct | Holding | 8,676 owned after | $307.51 exercise price | 2016-06-08 | |
| 2016-05-16 holding as of filing | Nicholson C. David Officer (Chief R&D Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $215.77 exercise price | 2016-05-16 | ||
| 2016-05-11 | Basgoz Nesli Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −459 459 owned after | $82.53 exercise price | 2016-05-12 |